Core Insights - Chemours shares have declined approximately 14% since the last earnings report, underperforming the S&P 500 [1] - The consensus estimate for Chemours has decreased by 62.75% over the past month, indicating a negative trend in estimates [2] Financial Performance - The most recent earnings report highlighted a downward trend in estimates, suggesting potential challenges ahead for Chemours [4] - Chemours currently holds a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4] Investment Scores - Chemours has a subpar Growth Score of D and a Momentum Score of F, but it received an A for Value, placing it in the top 20% for this investment strategy [3] - The aggregate VGM Score for Chemours is C, which is relevant for investors not focused on a single strategy [3]

The Chemours Company (CC) entered into an alliance with Energy Fuels Inc. to create and expand rare earth and critical mineral supply chains to meet increasing demand. This alliance is aimed at bettering the companies’ existing relationship and strengthening the U.S. domestic critical and rare earth mineral supply. Energy Fuels, a leading producer of rare earth elements, is expected to produce world-scale quantities of rare earth, titanium ilmenite and zircon minerals in the coming years. Chemours is engage ...

The Chemours Company (CC) reported a net loss of $8 million or 5 cents per share for fourth-quarter 2024 compared with the year-ago quarter's loss of $18 million or 12 cents.Barring one-time items, earnings came in at 11 cents per share. It beat the Zacks Consensus Estimate of 10 cents.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The company reported fourth-quarter net sales of $1,359 million, reflecting a 1% decline from the previous-year quarter. It fell short of the Zacks Consen ...

Analyst’s Disclosure: I/we have a beneficial long position in the shares of CC, BASFY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give financial ...

The Chemours Company (NYSE:CC) Q4 2024 Earnings Conference Call February 18, 2025 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - SVP and CFO Conference Call Participants Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Hassan Ahmed - Alembic Global Advisors John McNulty - BMO Vincent Andrews - Morgan Stanley John Roberts - Mizuho Laurence Alexander - Jefferies Jeff Zekauskas - JPMorgan Pete Osterland - Truist Operator Good morning. My n ...

Chemours (CC) reported $1.36 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 0.2%. EPS of $0.11 for the same period compares to $0.31 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.36 billion, representing a surprise of -0.06%. The company delivered an EPS surprise of +10.00%, with the consensus EPS estimate being $0.10.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

Fourth Quarter and Full Year 2024 Earnings Presentation February 18, 2025 Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current ...

Chemours (CC) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10%. A quarter ago, it was expected that this chemical company would post earnings of $0.32 per share when it actually produced earnings of $0.40, delivering a surprise of 25%.Over the last four quarters, the company has su ...

Thermal & Specialized Solutions - The Thermal & Specialized Solutions segment is a leading global provider of refrigerants and thermal management solutions, with a focus on low GWP and sustainable technologies like Opteon™, which was commercialized in 2016[30] - In 2023, the company announced the initial commercialization of Opteon™ 2P50, targeted for the first half of 2026, to meet increasing demands for cooling capacities driven by advancements in AI and computing[31] - The company plans to expand Opteon™ YF capacity at its Corpus Christi, Texas facility by approximately 40% to meet customer needs transitioning to lower GWP refrigerants, with mechanical completion expected in Q4 2024[31] - The company has a leadership position in fluorine chemistry and materials science, competing against major players like Honeywell and Daikin in the Thermal & Specialized Solutions segment[32] - Chemours aims to achieve a goal of avoiding 325 million tons of carbon dioxide equivalent emissions globally by the end of 2025 through its low GWP products[86] Titanium Technologies - The Titanium Technologies segment has a nameplate capacity of approximately 1.1 million metric tons per year for TiO2 pigment, with production facilities in the U.S. and Mexico[40] - The Titanium Technologies Transformation Plan achieved approximately $190 million in cost savings, with $140 million related to 2024 and $50 million related to 2023, following the shutdown of the Kuan Yin facility in Taiwan[45] - The worldwide demand for TiO2 pigment in 2024 was estimated at approximately 7.3 million metric tons, with nameplate capacity at around 9.9 million metric tons[47] - The Titanium Technologies segment's raw materials include titanium-bearing ores, chlorine, and calcined petroleum coke, sourced from multiple suppliers to ensure supply chain flexibility[50] - In 2024, the top 10 customers in the Titanium Technologies segment represented about 41% of net sales, with one customer exceeding 10% of net sales[58] - TiO2 pigment sales volume is typically highest in the second and third quarters due to seasonality influenced by weather and holiday seasons[59] - The Titanium Technologies business focuses on sustainability with the Ti-Pure™ Sustainability product series, enhancing product sustainability designations[90] - Energy costs account for approximately 10% of the production cost in TiO2 pigment manufacturing, with access to low-cost natural gas in U.S. and Mexico facilities[54] Advanced Performance Materials - The Advanced Performance Materials segment serves around 1,000 customers globally, with no single customer accounting for more than 10% of net sales in 2024[71] - The Advanced Performance Materials segment is positioned for growth driven by demand for clean energy and advanced electronics technologies[64] - Chemours launched operations at THE Mobility F.C. Membranes Company in 2023 to enhance fuel cell and humidifier membrane manufacturing capacity[62] Environmental Commitment - Chemours aims for a 60% absolute reduction in greenhouse gas emissions by 2030 and a 25% reduction in Scope 3 emissions per ton of product by 2030[84] - The company has successfully reduced Scope 1 and Scope 2 GHG emissions by 60% and achieved a 99% reduction in air and water process emissions of fluorinated organic chemicals[87] - The company is subject to significant compliance costs related to environmental laws and regulations, which may increase over time[92] - The board of directors established an Environmental, Health, Safety, and Operations Performance committee to oversee environmental and safety risk management[102] Employee and Workforce Management - Chemours has approximately 6,000 employees globally, with 77% located in the Americas, 16% in Europe, and 7% in Asia Pacific[96] - The company reported a voluntary attrition percentage of approximately 8% for the year ended December 31, 2024, indicating effective employee retention strategies[108] - Chemours is committed to transparency in pay practices, having implemented measures to ensure equitable remuneration across its workforce[107] Financial Management and Risk - Chemours utilizes derivative financial instruments to manage risks associated with foreign currency exchange rates and commodity prices[498] - As of December 31, 2024, the company had 11 foreign currency forward contracts with a gross notional U.S. dollar equivalent of $196 million, resulting in a fair value of less than $1 million[501] - The company recognized a net gain of $5 million in 2024 from non-designated foreign currency forward contracts, compared to a net loss of $7 million in 2023[501] - Under the cash flow hedge program, the company had 173 foreign currency forward contracts with a notional U.S. dollar equivalent of $178 million and a fair value of $7 million as of December 31, 2024[502] - The company reported a pre-tax gain of $7 million in 2024 from cash flow hedges, compared to a pre-tax loss of $2 million in 2023[502] - The company designated euro-denominated debt as a hedge, recognizing a pre-tax gain of $47 million in 2024, following a pre-tax loss of $27 million in 2023[503] - The company entered into a cross-currency swap to convert $600 million of senior unsecured notes into €567 million, with a fair value of $5 million as of December 31, 2024[504] - The company had two interest rate swaps with a notional U.S. dollar equivalent of $300 million, resulting in a fair value of negative $3 million as of December 31, 2024[506] - A pre-tax gain of $9 million was recognized in 2024 from interest rate swaps, compared to a pre-tax loss of $6 million in 2023[506] - As of December 31, 2024, one customer represented approximately 7% of total accounts and notes receivable, indicating a diversified customer base[507] - The company did not have any commodity derivative financial instruments in place as of December 31, 2024 and 2023, indicating a strategy to manage commodity price risks through sales contracts[509]

EXHIBIT 99.1 The Chemours Company Reports Fourth Quarter and Full Year 2024 Results Wilmington, Del., February 18, 2025 – The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced its financial results for the fourth quarter and full year 2024. Key Fourth Quarter 2024 Results & Highlights Key Full Year 2024 Results ...